Aberrant methylation of thrombospondin-1 and its association with reduced expression in gastric cardia adenocarcinoma

J Biomed Biotechnol. 2010:2010:721485. doi: 10.1155/2010/721485. Epub 2010 Mar 15.

Abstract

Aim: Investigate the promoter methylation of the Thrombospondin-1 (TSP1) gene in gastric cardia adenocarcinoma (GCA).

Methods: MSP approach, immunohistochemistry method, and RT-PCR were used respectively to examine the promoter methylation of TSP1, its protein and mRNA expression in tumors and corresponding normal tissues. The expression and concentration of TGF-beta1 were examined respectively by immunohistochemistry and ELISA method. The status of T cell immunity was examined by Flow cytometry analysis.

Results: TSP1 was methylated in 34/96 (35.4%) tumor specimens, which was significantly higher than that in corresponding normal tissues (P < .001). Protein and mRNA expression of TSP1 in GCA tumor tissues were reduced significantly and were associated with TSP1 methylation. The protein expression of TGF-beta1 was significantly higher in tumor tissues (P < .001) and was associated with TNM stage and histological differentiation. The concentration of active and total TGF-beta1 did not show significant difference between the GCA patients with hypermethylation of TSP1 and without methylation of TSP1 (P > .05). The function of T cell immunity was significantly different between the GCA patients with hypermethylation of TSP1 and without methylation of TSP1.

Conclusions: Epigenetic silencing of TSP1 gene by promoter hypermethylation may play an important role in GCA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adult
  • Aged
  • DNA Methylation
  • Down-Regulation / genetics
  • Female
  • Genetic Predisposition to Disease / genetics
  • Humans
  • Male
  • Middle Aged
  • Promoter Regions, Genetic / genetics*
  • Stomach Neoplasms / genetics*
  • Thrombospondin 1 / genetics*

Substances

  • Thrombospondin 1